anti-LYVE1 (LYVE1) 抗体产品概述

Full name:
anti-Lymphatic Vessel Endothelial Hyaluronan Receptor 1 抗体 (LYVE1)
在www.antibodies-online.cn可供281 Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) 抗体的26不同的供货商。 再加上,我们可以发LYVE1 蛋白 (34)LYVE1 试剂盒 (19)和数多这个蛋白质的别的产品。 总共344 LYVE1产品已列进来了。
别名:
1200012G08Rik, Crsbp-1, HAR, Lyve-1, LYVE1, Xlkd1

所有可销售的anti-LYVE1 抗体

您会转到已过滤好的搜索

引用最多的anti-LYVE1 抗体

  1. Mouse (Murine) Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN115689 : Jackson: The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. in Trends in cardiovascular medicine 2003 (PubMed)
    Show all 7 references for 115689

  2. Human Polyclonal LYVE1 Primary Antibody for EIA, IHC (p) - ABIN357391 : Cursiefen, Schlötzer-Schrehardt, Küchle, Sorokin, Breiteneder-Geleff, Alitalo, Jackson: Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. in Investigative ophthalmology & visual science 2002 (PubMed)
    Show all 5 references for 357391

  3. Mouse (Murine) Monoclonal LYVE1 Primary Antibody for FACS, IHC (p) - ABIN1449242 : Hirashima, Sano, Morisada, Murakami, Rossant, Suda: Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. in Developmental biology 2008 (PubMed)
    Show all 4 references for 1449242

  4. Human Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN115663 : Mouta Carreira, Nasser, di Tomaso, Padera, Boucher, Tomarev, Jain: LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. in Cancer research 2001 (PubMed)
    Show all 4 references for 115663

  5. Mouse (Murine) Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN126137 : Sleeman, Krishnan, Kirkin, Baumann: Markers for the lymphatic endothelium: in search of the holy grail? in Microscopy research and technique 2001 (PubMed)
    Show all 3 references for 126137

  6. Human Polyclonal LYVE1 Primary Antibody for EIA, IHC (p) - ABIN357392 : Cunnick, Jiang, Gomez, Mansel: Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. in Biochemical and biophysical research communications 2001 (PubMed)
    Show all 3 references for 357392

  7. Human Polyclonal LYVE1 Primary Antibody for WB - ABIN616055 : Heindl, Hofmann, Adler, Knorr, Holbach, Naumann, Kruse, Cursiefen: Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? in Ophthalmology 2010 (PubMed)
    Show all 2 references for 616055

  8. Human Polyclonal LYVE1 Primary Antibody for IHC (p), WB - ABIN388752 : Banerji, Ni, Wang, Clasper, Su, Tammi, Jones, Jackson: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. in The Journal of cell biology 1999 (PubMed)
    Show all 2 references for 388752

  9. Human Polyclonal LYVE1 Primary Antibody for IF (p), IHC (p) - ABIN674799 : Sun, Jia, Zhang, Liu, Zhang, Zhao: A reproducible in-vivo model of lymphatic malformation in rats. in Journal of comparative pathology 2011 (PubMed)
    Show all 2 references for 674799

  10. Cow (Bovine) Polyclonal LYVE1 Primary Antibody for WB - ABIN2782730 : Ishikawa, Akishima-Fukasawa, Ito, Akasaka, Yokoo, Ishii: Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. in Cancer 2008 (PubMed)

更多抗LYVE1的相互作用对抗体

Human Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. Dendritic cells (DCs) docked to the basolateral surface of lymphatic vessels and transited to the lumen through hyaluronan-mediated interactions with the lymph-specific endothelial receptor LYVE-1. Targeted deletion of the gene Lyve1, antibody blockade or depletion of the DC hyaluronan coat not only delayed lymphatic trafficking of dermal DCs but also blunted their capacity to prime CD8 (显示 CD8A 抗体)(+) T cell responses in LNs.

  2. These findings reveal binding is dependent not just on clustering but also on the biochemical properties of LYVE-1 homodimers. They also mark LYVE-1 as the first Link protein (显示 HAPLN1 抗体) superfamily member requiring covalent homodimerization for function and suggest the interchain disulfide acts as a redox switch in vivo.

  3. LYVE1 expression is significantly upregulated in human masticatory mucosa during wound healing

  4. Immunostaining analyses in psoria (显示 VEGFA 抗体)sis skin lesions suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.

  5. These results demonstrate the prerequisite of a critical LYVE-1 threshold density and show that hyaluronan binding may be elicited in lymphatic endothelium by surface clustering with divalent LYVE-1 mAbs.

  6. We have established a novel, three-protein biomarker panel that is able to detect patients with early-stage pancreatic cancer in urine specimens:LYVE-1, REG1A (显示 REG1A 抗体), and TFF1 (显示 TFF1 抗体) were selected as candidate biomarkers

  7. Data (including data from studies in knockout mice) suggest LYVE1 mediates adhesion of group A Streptococci (GAS) to lymphatic vesicular endothelium via capsular hyaluronan; this appears to be critical factor for lymphatic trafficking of GAS in vivo.

  8. High expression of LYVE-1 is associated with atherosclerotic arteries.

  9. Data indicate that detection of lymphatic vascular invasion (LVI) can be optimized by specific D2-40 or LYVE-1 staining.

  10. High-low cell surface HA content of tumor cells through the interaction with LYVE-1 leads to adhesion differences.

Mouse (Murine) Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. Dendritic cells (DCs) docked to the basolateral surface of lymphatic vessels and transited to the lumen through hyaluronan-mediated interactions with the lymph-specific endothelial receptor LYVE-1. Targeted deletion of the gene Lyve1, antibody blockade or depletion of the DC hyaluronan coat not only delayed lymphatic trafficking of dermal DCs but also blunted their capacity to prime CD8 (显示 CD8A 抗体)(+) T cell responses in LNs.

  2. the LYVE-1-expressing cells might be involved in the uptake of hyaluronan and other waste products as well as foreign particles circulating in the blood and lymph while participating in the subsequent degradation in relay with adjacent macrophage populations.

  3. Immunostaining analyses in VEGF-A (显示 VEGFA 抗体) transgenic skin suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.

  4. Endogenous hyaluronan on the surface of macrophages can engage LYVE-1, facilitating their adhesion and transit across lymphatic endothelium.

  5. MT1-MMP (显示 MMP14 抗体) directly cleaves LYVE-1 on lymphatic endothelial cells to inhibit LYVE-1-mediated lymphangiogenic responses and restrains the production of VEGF-C (显示 VEGFC 抗体).

  6. Data (including data from studies in knockout mice) suggest Lyve1 mediates adhesion of group A Streptococci (GAS) to lymphatic vesicular endothelium via capsular hyaluronan; this appears to be critical factor for lymphatic trafficking of GAS in vivo.

  7. Data show that the expression of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE 1) was similar with vascular endothelial growth factor C (VEGF-C (显示 VEGFC 抗体)), but its peak appeared 1-2 d later than that of VEGF-C (显示 VEGFC 抗体).

  8. LMW-HA may play a critical role in the processes required for lymphangiogenesis through interactions with its receptor LYVE-1 and triggering intracellular signal cascades.

  9. Studied the specific targeting property of lymphatic vessel endothelial hyaluronan receptor-1 binding polyethylene glycol-coated ultrasmall superparamagnetic iron oxide (LYVE-1-PEG (显示 PAEP 抗体)-USPIO) nanoparticles to mouse lymphatic endothelial cells.

  10. Reelin (显示 RELN 抗体)-deficient mice showed abnormal collecting lymphatic vessels, characterized by a reduced number of SMCs, abnormal expression of lymphatic capillary marker lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), and impaired function

Cow (Bovine) Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. CRSBP-1 plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence.

LYVE1 抗原简介

Antigen Summary

This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis.

Alternative names and synonyms associated with LYVE1

  • lymphatic vessel endothelial hyaluronic acid receptor 1-like (LOC560618) 抗体
  • lymphatic vessel endothelial hyaluronan receptor 1 (LOC100347960) 抗体
  • lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) 抗体
  • lymphatic vessel endothelial hyaluronan receptor 1 (Lyve1) 抗体
  • 1200012G08Rik 抗体
  • Crsbp-1 抗体
  • HAR 抗体
  • Lyve-1 抗体
  • LYVE1 抗体
  • Xlkd1 抗体

Protein level used designations for LYVE1

lymphatic vessel endothelial hyaluronan receptor 1 , extracellular link domain containing 1 , lymphatic endothelial hyaluronan receptor LYVE-1 , lymphatic vessel endothelial hyaluronic acid receptor 1 , cell surface retention sequence binding protein-1 , cell surface retention sequence-binding protein 1 , extracellular link domain-containing 1 , extracellular link domain-containing protein 1 , hyaluronic acid receptor , extra cellular link domain-containing 1 , lymphatic vessel endothelial HA receptor-1 , lymphatic vessel endothelial HA recptor-1

GENE ID SPECIES
560618 Danio rerio
100347960 Oryctolagus cuniculus
397626 Sus scrofa
423038 Gallus gallus
451024 Pan troglodytes
611529 Canis lupus familiaris
702941 Macaca mulatta
10894 Homo sapiens
114332 Mus musculus
293186 Rattus norvegicus
404179 Bos taurus
anti-LYVE1 (LYVE1) 抗体 精选生产商
您还需要查找其他产品吗?